Akt is a direct target for myricetin to inhibit cell transformation

Akt, a serine/threonine kinase, is a critical regulator in many cellular processes including cell growth, proliferation, and apoptosis. In this study, we found that myricetin, a typical flavonol existing in many fruits and vegetables, could directly target Akt to inhibit cell transformation. Binding assay revealed that myricetin bound to Akt directly by competing with ATP. In vitro and ex vivo data confirmed that myricetin inhibited the phosphorylation and kinase activity of Akt. Molecular modeling suggested that myricetin easily docks to the ATP-binding site of Akt with hydrogen bonds. Signaling analysis data further demonstrated that myricetin inhibited Akt-mediated activator protein-1 (AP-1) transactivation, cyclin D1 expression and cell transformation. Overall, our results indicate that Akt is a direct target for myricetin to inhibit cell transformation.

[1]  D. Hou,et al.  Stabilization of p53 Is Involved in Quercetin-Induced Cell Cycle Arrest and Apoptosis in HepG2 Cells , 2008, Bioscience, biotechnology, and biochemistry.

[2]  Junichi Goto,et al.  ASEDock-Docking Based on Alpha Spheres and Excluded Volumes , 2008, J. Chem. Inf. Model..

[3]  M. Ding,et al.  The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. , 2007, Cancer research.

[4]  Weiya Ma,et al.  Involvement of the Akt/mTOR pathway on EGF‐induced cell transformation , 2003, Molecular carcinogenesis.

[5]  Jie Zhou,et al.  Akt1 governs breast cancer progression in vivo , 2007, Proceedings of the National Academy of Sciences.

[6]  B. Hemmings,et al.  Structure, regulation and function of PKB/AKT--a major therapeutic target. , 2004, Biochimica et biophysica acta.

[7]  C. Kumar,et al.  AKT crystal structure and AKT-specific inhibitors , 2005, Oncogene.

[8]  D. Hou,et al.  Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. , 2007, Free radical biology & medicine.

[9]  I. Eto.  Promotion‐sensitive epidermal and mammary epithelial cells maintained in suspension over agarose , 1998, Cell proliferation.

[10]  Weiya Ma,et al.  Inhibitory Mechanisms of Tea Polyphenols on the Ultraviolet B-activated Phosphatidylinositol 3-Kinase-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[11]  N. Kang,et al.  Myricetin down-regulates phorbol ester-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking activation of nuclear factor kappa B. , 2007, Journal of agricultural and food chemistry.

[12]  Weiya Ma,et al.  Phosphatidylinositol-3 Kinase Is Necessary for 12-O-Tetradecanoylphorbol-13-acetate-induced Cell Transformation and Activated Protein 1 Activation* , 1997, The Journal of Biological Chemistry.

[13]  N. Colburn,et al.  Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. , 2000, Free radical biology & medicine.

[14]  J. Paramio,et al.  Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. , 2007, Cancer research.

[15]  B. Hemmings,et al.  PKB and the mitochondria: AKTing on apoptosis. , 2008, Cellular signalling.

[16]  De-Xing Hou,et al.  Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. , 2003, Carcinogenesis.

[17]  W. Willett,et al.  Flavonoid intake and colorectal cancer risk in men and women. , 2006, American journal of epidemiology.

[18]  D. Hou,et al.  Myricetin directly targets JAK1 to inhibit cell transformation. , 2009, Cancer letters.

[19]  H. Khoo,et al.  Biological effects of myricetin. , 1997, General pharmacology.

[20]  S. Lin-Shiau,et al.  Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. , 1999, European journal of cancer.

[21]  K. M. Nicholson,et al.  The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.

[22]  N. Colburn,et al.  Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis , 2000 .

[23]  I. Eto.  Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: implication in phorbol ester‐induced tumour promotion , 2000, Cell proliferation.

[24]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[25]  N. Kang,et al.  MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. , 2009, Biochemical pharmacology.

[26]  S. Epstein,et al.  Akt Controls Vascular Smooth Muscle Cell Proliferation In Vitro and In Vivo by Delaying G1/S Exit , 2003, Circulation research.

[27]  J. Massagué,et al.  G1 cell-cycle control and cancer , 2004, Nature.

[28]  H. Khoo,et al.  REVIEW Biological Effects of Myricetin , 1997 .

[29]  H. Mukhtar,et al.  Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. , 1988, Cancer research.

[30]  P. Kuo.  Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63. , 2005, Life sciences.

[31]  E. A. Rogozin,et al.  Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. , 2007, Carcinogenesis.

[32]  A. Bode,et al.  Myricetin suppresses UVB-induced skin cancer by targeting Fyn. , 2008, Cancer research.